Innovacell Secures Approval for IPO on Tokyo Stock Exchange in 2026 Innovacell, a firm specializing in cell therapy, has received IPO approval for its shares on the Tokyo Stock Exchange, set for early 2026.

Innovacell Secures Approval for IPO on Tokyo Stock Exchange in 2026 #Japan #Tokyo #Innovacell #Hifumi #Rheaos